Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Press Releases for Monday, September 12, 2022
Comprehensive Power Purchase Agreement Online Workshop is Now Open for Registration 
17:24 HKT/SGT
Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma 
14:37 HKT/SGT
HKTDC Hong Kong Watch & Clock Fair and Salon de TE conclude 
14:00 HKT/SGT
AVIA Releases OTT Study in Singapore at its First OTT Upfront Showcase Presenting Premium Content at its Best 
13:02 HKT/SGT
TOYOTA GAZOO Racing concludes a rocky Acropolis weekend 
10:23 HKT/SGT
One-two home victory for TOYOTA GAZOO Racing 
10:00 HKT/SGT
Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022 
08:00 HKT/SGT
 ACN Search:
 
 RSS  
 News Alerts
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: